Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 3 Randomized Controlled Study of Renal Autologous Cell Therapy (REACT) in Subjects With Type 2 Diabetes and Chronic Kidney Disease (REGEN-006)
Sponsored by IQVIA RDS Inc.
Active
$770.6K Funding
4 People
External
Related Topics
cell therapy,
diabetes,
chronic kidney disease,
clinical trial,
renal therapy
People
Stephanie Soto
(CD)
Cancer Center Division
﹒Clinical Research Coordinator III
Bijin Thajudeen
Principal Investigator (PI)
Medicine
﹒Associate Professor, Medicine - (Clinical Scholar Track)
Gregory Woodhead
Co-Investigator (COI)
Medical Imaging
﹒Assistant Professor
Katherine Mendoza
(CD)
Epidemiology and Biostatistics
﹒Research Manager II